[HTML][HTML] Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Q Zhu, Z Chen, PK Paul, Y Lu, W Wu, J Qi - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules
than small molecular drugs due to their high selectivity and efficacy, but fewer side effects …

Nanoparticles for oral delivery: Design, evaluation and state-of-the-art

AA Date, J Hanes, LM Ensign - Journal of Controlled Release, 2016 - Elsevier
The oral route is a preferred method of drug administration, though achieving effective drug
delivery and minimizing off-target side effects is often challenging. Formulation into …

[HTML][HTML] Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review

M Abd Elgadir, MS Uddin, S Ferdosh, A Adam… - Journal of food and drug …, 2015 - Elsevier
Chitosan is a promising biopolymer for drug delivery systems. Because of its beneficial
properties, chitosan is widely used in biomedical and pharmaceutical fields. In this review …

Approaches for enhancing oral bioavailability of peptides and proteins

J Renukuntla, AD Vadlapudi, A Patel… - International journal of …, 2013 - Elsevier
Oral delivery of peptide and protein drugs faces immense challenge partially due to the
gastrointestinal (GI) environment. In spite of considerable efforts by industrial and academic …

Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin

CY Wong, H Al-Salami, CR Dass - International journal of pharmaceutics, 2018 - Elsevier
Diabetes mellitus is a chronic metabolic health disease affecting the homeostasis of blood
sugar levels. However, subcutaneous injection of insulin can lead to patient non …

Hydrogel nanoparticles in drug delivery

M Hamidi, A Azadi, P Rafiei - Advanced drug delivery reviews, 2008 - Elsevier
Hydrogel nanoparticles have gained considerable attention in recent years as one of the
most promising nanoparticulate drug delivery systems owing to their unique potentials via …

Glycosaminoglycans: key players in cancer cell biology and treatment

N Afratis, C Gialeli, D Nikitovic, T Tsegenidis… - The FEBS …, 2012 - Wiley Online Library
Glycosaminoglycans are natural heteropolysaccharides that are present in every
mammalian tissue. They are composed of repeating disaccharide units that consist of either …

Lipid-based nanocarriers for oral peptide delivery

Z Niu, I Conejos-Sánchez, BT Griffin… - Advanced drug delivery …, 2016 - Elsevier
This article is aimed to overview the lipid-based nanostructures designed so far for the oral
administration of peptides and proteins, and to analyze the influence of their composition …

First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics

B Wu, K Kulkarni, S Basu, S Zhang, M Hu - Journal of pharmaceutical …, 2011 - Elsevier
Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is a significant
metabolic pathway that facilitates efficient elimination of numerous endobiotics and …

Anti-cancer activities of pH-or heat-modified pectin

L Leclere, PV Cutsem, C Michiels - Frontiers in pharmacology, 2013 - frontiersin.org
Despite enormous efforts that have been made in the search for novel drugs and treatments,
cancer continues to be a major public health problem. Moreover, the emergence of …